Mark Watson, MD, PhD
Biospecimen Core Co-Director, Pancreas SPORE
Associate Professor, Pathology and Immunology, Department of Pathology and Immunology, Washington University School of Medicine
Dr. Watson's laboratory is interested in characterizing sets of human genes whose expression pattern may be used to design new diagnostic tests and treatment strategies for solid tumors. He is using high-density oligonucleotide arrays (GeneChips) to perform gene expression profiling on biopsy specimens from patients with breast, pancreatic, prostate, lung and other carcinomas. Patterns of gene expression are correlated with traditional histopathology data and clinical outcomes to identify diagnostic signatures.